Literature DB >> 9794342

A new casemix adjustment index for hospital mortality among patients with congestive heart failure.

C A Polanczyk1, L E Rohde, E A Philbin, T G Di Salvo.   

Abstract

OBJECTIVES: Comparative analysis of hospital outcomes requires reliable adjustment for casemix. Although congestive heart failure is one of the most common indications for hospitalization, congestive heart failure casemix adjustment has not been widely studied. The purposes of this study were (1) to describe and validate a new congestive heart failure-specific casemix adjustment index to predict in-hospital mortality and (2) to compare its performance to the Charlson comorbidity index.
METHODS: Data from all 4,608 admissions to the Massachusetts General Hospital from January 1990 to July 1996 with a principal ICD-9-CM discharge diagnosis of congestive heart failure were evaluated. Massachusetts General Hospital patients were randomly divided in a derivation and a validation set. By logistic regression, odds ratios for in-hospital death were computed and weights were assigned to construct a new predictive index in the derivation set. The performance of the index was tested in an internal Massachusetts General Hospital validation set and in a non-Massachusetts General Hospital external validation set incorporating data from all 1995 New York state hospital discharges with a primary discharge diagnosis of congestive heart failure.
RESULTS: Overall in-hospital mortality was 6.4%. Based on the new index, patients were assigned to six categories with incrementally increasing hospital mortality rates ranging from 0.5% to 31%. By logistic regression, "c" statistics of the congestive heart failure-specific index (0.83 and 0.78, derivation and validation set) were significantly superior to the Charlson index (0.66). Similar incrementally increasing hospital mortality rates were observed in the New York database with the congestive heart failure-specific index ("c" statistics 0.75).
CONCLUSION: In an administrative database, this congestive heart failure-specific index may be a more adequate casemix adjustment tool to predict hospital mortality in patients hospitalized for congestive heart failure.

Entities:  

Mesh:

Year:  1998        PMID: 9794342     DOI: 10.1097/00005650-199810000-00007

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  6 in total

1.  Biomarker changes during acute heart failure treatment.

Authors:  Brent Boyer; Kimberly W Hart; Matthew I Sperling; Christopher J Lindsell; Sean P Collins
Journal:  Congest Heart Fail       Date:  2011-10-17

2.  Prediction of mortality for congestive heart failure patients: results from different wards of an Italian teaching hospital.

Authors:  N Nante; M F De Marco; D Balzi; P Addari; E Buiatti
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Psychiatric comorbidity and mortality among veterans hospitalized for congestive heart failure.

Authors:  Jim E Banta; Ronald M Andersen; Alexander S Young; Gerald Kominski; William E Cunningham
Journal:  Mil Med       Date:  2010-10       Impact factor: 1.437

4.  Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies.

Authors:  Sean P Collins; Christopher J Lindsell; Cathy A Jenkins; Frank E Harrell; Gregory J Fermann; Karen F Miller; Sue N Roll; Matthew I Sperling; David J Maron; Allen J Naftilan; John A McPherson; Neal L Weintraub; Douglas B Sawyer; Alan B Storrow
Journal:  Am Heart J       Date:  2012-10-29       Impact factor: 4.749

5.  Covariate balance in a Bayesian propensity score analysis of beta blocker therapy in heart failure patients.

Authors:  Lawrence C McCandless; Paul Gustafson; Peter C Austin; Adrian R Levy
Journal:  Epidemiol Perspect Innov       Date:  2009-09-10

6.  Causes and Predictors of In-Hospital Mortality in Patients Admitted with or for Heart Failure at a Tertiary Hospital in Brazil.

Authors:  André Wajner; Priccila Zuchinali; Vírgilio Olsen; Carisi A Polanczyk; Luis Eduardo Rohde
Journal:  Arq Bras Cardiol       Date:  2017-09-28       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.